BioCentury
ARTICLE | Company News

FDA approves Horizon's Duexis

April 25, 2011 11:49 PM UTC

FDA approved an NDA from Horizon Pharma Inc. (Northbrook, Ill.) for Duexis ibuprofen/famotidine for the relief of signs and symptoms of rheumatoid arthritis (RA) and osteoarthritis (OA) and to decreas...